Please login to the form below

Not currently logged in
Email:
Password:

Stage Cell Therapeutics

This page shows the latest Stage Cell Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Juno boosts CAR-T presence with $80m German acquisition

Juno boosts CAR-T presence with $80m German acquisition

Juno boosts CAR-T presence with $80m German acquisition. Stage Cell Therapeutics will contribute in process development and manufacturing. ... Juno Therapeutics has laid claim to another piece of the immuno-oncology territory by buying Germany's Stage

Latest news

  • Going for gold

    Cell Therapeutics is conducting late-stage clinical development with its solvent-free formulation ñ paclitaxel poliglumex (Xyotax). ... The paclitaxel then releases from the polymer and becomes active. Cell Therapeutics is currently conducting phase III

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    Last in its hat trick of deals this month was Juno's acquisition of Stage Cell Therapeutics for an initial payment of $59m with $150m in success payments. ... 900. Editas/Juno Therapeutics. Collaboration. Development of next generation CAR-T and TRC cell

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics